Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration?

Huntington's disease (HD) is a progressive neurodegenerative disorder for which, until now, only symptomatic treatment has been available. Lately, there have been multiple ongoing clinical trials targeting therapeutic agents for preventing disease onset or slowing disease progression in HD. These st...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Clancy Cerejo, Nicolas De Cleene, Elias Mandler, Katarina Schwarzová, Samuel Labrecque, Philipp Mahlknecht, Florian Krismer, Atbin Djamshidian, Klaus Seppi, Beatrice Heim
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-01-01
Edice:	Neurology International
Témata:	Huntington's disease optical coherence tomography neurodegeneration
On-line přístup:	https://www.mdpi.com/2035-8377/17/1/13
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!